New Drug Shrinks Lung Tumors by 92 Percent

Monday, 09 Sep 2013 10:17 AM

 

Share:
  Comment  |
   Contact Us  |
  Print  
|  A   A  
  Copy Shortlink
Oncolytics Biotech Inc said its cancer drug Reolysin reduced the size of tumors in 92 percent of lung cancer patients in a mid-stage trial.

The company's shares rose as much as 22 percent to $3.22 in trading before the bell.

The drug was tested on patients suffering from advanced squamous cell carcinoma of the lung. It was used intravenously in combination with chemotherapy drugs carboplatin and paclitaxel.

Special: This Small Group of Doctors is Quietly Curing Cancer

"Squamous cell carcinoma of the lung is notoriously difficult to treat, and these results support further investigation of Reolysin in randomized clinical trials for this indication," Chief Executive Brad Thompson said in a statement on Monday.

Squamous cell carcinomas account for 25 percent to 30 percent of all lung cancers, according to the American Cancer Society.

Final progression-free survival and safety data for the study will be reported later in the year, the Calgary-based company said.

© 2014 Thomson/Reuters. All rights reserved.

Share:
  Comment  |
   Contact Us  |
  Print  
  Copy Shortlink
Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Retype Email:
Country
Zip Code:
Privacy: We never share your email.
 
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
Top Stories
You May Also Like

Zapping Scalp With Electrical Current Boosts Memory: Scientists

Friday, 29 Aug 2014 08:24 AM

Scientists have found that sending electrical currents through the scalp to a specific network of brain structures can e . . .

Kids Who Lack Sleep Often Become Obese Adults: Study

Friday, 29 Aug 2014 08:17 AM

Lack of sleep not only puts teens at risk for poor grades, it also puts them at increased risk for obesity, researchers  . . .

FDA OKs Cellphone Apps That Monitor Heart Function

Friday, 29 Aug 2014 08:11 AM

For a growing U.S. aging population, tracking heart health via a smartphone can mean the difference between life and dea . . .

Most Commented

Newsmax, Moneynews, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, NewsmaxWorld, NewsmaxHealth, are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved